查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1461236

癌症资讯系统市场评估：依产品和服务、应用、最终用户和地区划分的机会和预测（2017-2031）

Oncology Information System Market Assessment, By Product and Service, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 220 Pages | 商品交期: 3-5个工作天内

价格

全球癌症资讯系统市场规模将从2023年的32.3亿美元成长到2031年的57亿美元，在2024年至2031年的预测期内复合年增长率为7.35%。

癌症资讯系统 (OIS) 市场的成长主要是由全球癌症患者数量不断增加所推动的。 对 OIS 简化患者资讯和资料管理的需求不断增长，促使不同类型的 OIS 软体激增。 此外，公司增加对癌症研究的投资预计将推动市场扩张。 根据世界卫生组织 (WHO) 到 2030 年消除子宫颈癌这个公共卫生问题的目标，各国政府正在增加癌症研发的资金。 此类举措不仅提高了意识，也推动了市场成长。

癌症病人增加：

由于癌症仍然是全球死亡的重要原因，技术和软体系统的整合在癌症治疗中发挥重要作用。 由于生活方式的改变，癌症发生率不断上升，尤其是在老年人中，这是对癌症治疗资讯系统需求的主要驱动力。 预计到 2022 年，将有 2,000 万人被诊断出罹患癌症，970 万人将死亡，约 5,350 万人将在诊断后五年内生存。 统计数据显示，五分之一的人一生中将面临癌症诊断，九分之一的男性和十二分之一的女性将受到这种疾病的影响。 人们正在采用电子健康记录（EHR）系统来支援医疗保健专业人员的循证决策并简化患者护理协调。 癌症资讯系统管理电子病历，改善以病人为中心的服务，瞭解疾病的病因，实现疾病的早期发现，并促进获得更有效的治疗。 为了确保患者在治疗期间接受准确的辐射剂量，对准确、高效的辐射检测系统的需求至关重要。 癌症治疗的进展正在朝着精准医学和客製化治疗计画的方向发展，凸显了利用资讯系统有效利用先进技术诊断结果的重要性。 这些系统储存、处理和共享文檔，从而可以对诊断进行彻底分析并制定适当的治疗策略。 根据美国癌症协会杂誌2022年1月发表的一篇文章，美国报告的癌症病例数已增加至约190万例。

医疗保健 IT 的快速成长

医疗保健IT市场与医疗技术、医疗保健、医疗器材、数位健康等各个领域交叉，现代科技进步正在重塑传统的医疗保健服务和研究系统。 整合的医疗保健 IT 生态系统可解决癌症照护连续性方面的差距，同时简化流程并降低效率。 最大限度地减少医疗冗余，使医院系统能够跨提供者无缝提供以患者为中心的护理。 透过采用各种医疗保健 IT 解决方案，包括 EMR、RIS、PACS、VNA 和治疗计划解决方案，医疗保健组织可以提高护理质量，同时降低营运费用并满足关键最终用户群的需求。

与传统的本地解决方案相比，基于云端的解决方案具有众多优势，包括更高的可访问性、可扩展性和成本效益。 基于云端的解决方案促进与 EHR 系统和其他医疗保健 IT 平台的无缝集成，促进不同医疗保健环境之间的患者资料共享和协作。 人工智慧和机器学习演算法简化了复杂医学影像数据的分析和解释，提高了癌症诊断和治疗计划的准确性和效率。

本报告调查了全球癌症资讯系统市场，提供了市场定义和概述、市场规模趋势和预测、各个细分市场和地区的详细分析、行业结构以及影响市场成长的因素。等等。

目录

第一章研究方法

第 2 章专案范围与定义

第 3 章执行摘要

第四章癌症资讯系统市场展望

  • 市场规模/预测
  • 依产品/服务
    • 病患资讯系统
    • 治疗计画系统
    • 治疗管理/医学影像分析系统
    • 咨询与优化服务
    • 实施服务
    • 售后服务/维修服务
  • 依用途
    • 肿瘤学
    • 放射肿瘤
    • 肿瘤外科
  • 依最终用户
    • 医院
    • 癌症护理中心
    • 政府机构
    • 研究设施
    • 其他
  • 依地区
    • 北美
    • 欧洲
    • 亚太地区
    • 南美洲
    • 中东/非洲
  • 各公司的市占率

第 5 章癌症资讯系统市场展望：依地区

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东/非洲

第 6 章市场映射

  • 依产品和服务
  • 依用途
  • 依最终用户
  • 依地区

第七章宏观环境与产业结构

  • 需求与供给分析
  • 汇入/汇出分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市场动态

  • 生长促进因素
  • 抑製成长的因素（问题/障碍）

第 9 章监理架构与创新

  • 专利情况
  • 创新/新兴技术

第十章主要公司状况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 位市场领导者的市场收入分析
  • 併购/合资企业（如果适用）
  • SWOT 分析（5 家参与公司）

第 11 章案例研究

第十二章主要公司展望

  • Siemens Healthineers
  • F. Hoffmann-La Roche AG
  • McKesson Corporation
  • Koninklijke Philips N.V.
  • GE HealthCare Technologies, Inc.
  • Elekta Medical Systems India Pvt. Ltd.
  • IBM Watson Health
  • Oracle Cerner
  • Epic Systems Corporation
  • RaySearch Laboratories AB

第 13 章策略建议

第十四章查询/免责声明

Product Code: MX11236

Global oncology information system market is projected to witness a CAGR of 7.35% during the forecast period 2024-2031, growing from USD 3.23 billion in 2023 to USD 5.7 billion in 2031. The growth of the oncology information system (OIS) market is primarily fueled by the increasing prevalence of cancer cases worldwide. There's a rising demand for OIS to streamline patient information and data management, leading to a surge in various types of OIS software. Additionally, increasing investments in cancer research by companies are anticipated to propel market expansion. Governments are increasing their funding for oncology research and development, aligning with the World Health Organization's goal of eliminating cervical cancer as a public health concern by 2030. Such initiatives not only raise awareness but also drive market growth.

In August 2022, the Koita Centre for Digital Oncology (KCDO) was established by the National Cancer Grid (NCG) to promote digital technology and tools for enhancing cancer care across India. The Koita Foundation provided funding for the center's establishment, with commitments for continued support over the next five years. An MoU was signed between the Tata Memorial Centre and Koita Foundation at the Tata Memorial Hospital in Mumbai. These initiatives were expected to contribute to market growth and enhance cancer care in India. The KCDO aims to serve as a platform for collaboration and knowledge exchange among oncology healthcare professionals, researchers, and innovators. Moreover, the center plans to develop and implement digital solutions to enhance cancer screening, diagnosis, and treatment outcomes.

Rising Occurrence of Cancer Cases

The integration of technology and software systems plays a vital role in cancer treatment, given that cancer remains a significant global cause of mortality. The increasing prevalence of cancer, particularly among the elderly due to lifestyle changes, is a key driver for the demand for oncology information systems. Projections for 2022 anticipated 20 million new cancer cases and 9.7 million deaths from the disease, with approximately 53.5 million survivors within five years of diagnosis. Statistics show that one in five individuals will face a cancer diagnosis during their lifetime, with one in nine men and one in twelve women succumbing to the disease. Electronic health record (EHR) systems are being adopted to support evidence-based decision-making among healthcare professionals and streamline patient care coordination. Oncology information systems manage EHRs, improving patient-centric services, understanding disease etiology, enabling early disease detection, and facilitating access to more effective treatment modalities. The demand for precise and efficient radiation detection systems is critical for ensuring patients receive accurate radiation dosages during treatment. Advancements in cancer care are moving towards precision medicine and tailored treatment plans, emphasizing the importance of leveraging information systems to utilize diagnostic results from advanced technologies effectively. These systems store, process, and share documentation, enabling thorough analysis of diagnoses and the formulation of appropriate treatment strategies. As per an article published in January 2022, by the American Cancer Society Journal, the number of cancer cases reported has increased to approximately 1.9 million in the United States.

Rapid Growth in Healthcare IT

The healthcare IT market intersects with various sectors, including medical technology, healthcare, medical devices, and digital health, reshaping traditional healthcare delivery and research systems through modern technological advancements. An integrated healthcare IT ecosystem addresses gaps in oncology care continuity while streamlining processes and reducing inefficiencies. It minimizes healthcare redundancies, enabling hospital systems to deliver patient-centric care seamlessly across healthcare providers. Consequently, adopting different healthcare IT solutions, such as EMR, RIS, PACS, VNA, and treatment planning solutions, has led healthcare organizations to decrease operational expenses while enhancing the quality of care, driving market demand among major end-user segments.

The market is propelled by the increasing adoption of cloud-based solutions, which offer numerous advantages over traditional on-premises alternatives, including enhanced accessibility, scalability, and cost-effectiveness. Cloud-based solutions facilitate seamless integration with EHR systems and other healthcare IT platforms, facilitating the sharing and collaboration of patient data across various healthcare settings. AI and ML algorithms streamline the analysis and interpretation of intricate medical imaging data, enhancing cancer diagnosis and treatment planning accuracy and efficiency.

In February 2023, New Jersey Cancer Care announced the commencement of remote patient monitoring services to drive innovation in oncology. The cancer care center integrates medical devices with patient apps through this initiative, fostering a more connected and proactive approach to patient care.

Dominance of Radiation Oncology

Through the projected period, radiation oncology is expected to experience significant growth at an impressive CAGR. Radiation therapy constitutes a vital aspect of cancer treatment, given the global prominence of cancer as a leading cause of mortality. With the increasing adoption of radiosurgery, the demand for radiation oncology has surged, leading radiological departments to generate extensive data on cancer cases. Effective radiation therapy necessitates treatment planning and simulation to precisely administer radiation doses to target tumors while minimizing harm to surrounding healthy tissues. Oncology information systems offer specialized tools and modules tailored for radiation treatment planning, encompassing dose calculations, treatment simulations, contouring, and image fusion. These systems empower radiation oncologists to devise optimal treatment strategies and simulate the delivery process, ensuring precision and safety. Furthermore, the growing global demand for radiation therapies in cancer treatment catalyzes the segment's expansion. The imperative for precise and efficient radiation detection systems arises to ensure patients receive the correct radiation dosage during treatment. Diagnostic imaging techniques employing ionizing radiation, such as CT scans, PET scans, and X-rays, play a crucial role in cancer diagnosis. Increased government investment in healthcare, as evidenced by data from the National Institutes of Health indicating a rise in US healthcare expenditure for biomedical imaging from USD 2.7 billion in 2022 to USD 3.1 billion in 2023, is also driving the demand for oncology information systems. In February 2024, Kormek Group was awarded £1.3 million (USD 1.6 million) to participate in the Intelligent Radiation Sensor Readout System (i-RASE) project for developing a new class of radiation sensors powered by artificial intelligence (AI).

North America Is Dominating the Global Oncology Information System Market

North America is poised to dominate the oncology information system market throughout the projected timeframe. This can be attributed to factors like the increasing incidence of cancer and the presence of advanced healthcare infrastructure. According to the cancer facts and figures report for 2023 from the American Cancer Society, approximately 1.9 million new cancer cases are expected to be diagnosed in 2023. Notably, prostate cancer is projected to lead with an estimated 288,300 cases, followed by lung cancer with 238,340 cases, and female breast cancer with 300,590 cases. Similarly, data released by the Government of Canada in May 2022 revealed that around 233,900 Canadians received cancer diagnoses in 2022, with prostate cancer anticipated to remain the most diagnosed cancer type. Additionally, increasing awareness campaigns related to cancer are anticipated to drive market growth in the region. The cancer awareness month in September in the United States highlights the government's commitment to support patients and their families, improving access to care, and promoting the importance of early detection. These efforts are likely to raise awareness about cancer and contribute to market expansion in North America over the forecast period.

Future Market Scenario (2024 - 2031F)

The rise in cancer patients presents the biggest opportunity for the growing oncology information system market. Advanced and effective approaches have been devised to ensure faster recovery and better results for keeping health in check for cancer patients. R&D and heavy investments made by healthcare giants are promoting developments in the oncology information system market, and this is a huge advantage for this market to flourish in the coming years. New companies in this area are introducing themselves with cutting-edge technologies. In May 2022, Berry Oncology, a firm specializing in genetic testing and early tumor screening, introduced a HIFI system comprising HIFI-det liquid biopsy technology and the corresponding HIFI-cal algorithm series. Successful attempts made towards the betterment of technology also pushes people to further engage with a higher quality of self-care and this paves a way for the market to rise.

Key Players Landscape and Outlook

Several companies, such as Siemens Healthineers, F. Hoffmann-La Roche AG, McKesson Corporation, Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Elekta AB, IBM Corporation, Oracle Cerner, Epic Systems Corporation, and RaySearch Laboratories AB, are focusing on market expansion and product launch and development. Oncology information system market participants are poised to encounter promising growth prospects in the global market, driven by the increasing demand for healthcare IT solutions. The primary focus of these leading players is directed towards the rapidly expanding market segment, aiming to thrive and excel in an intensely competitive market environment. Additionally, these market players emphasize collaboration and license agreements as strategic initiatives anticipated to propel market growth.

In May 2022, GE Healthcare partnered with RaySearch Laboratories AB, a provider of radiation oncology software, to develop an innovative radiation therapy simulation and treatment planning workflow solution. This collaboration aims to streamline the radiation targeting process to reduce tumor size.

In September 2022, the International Agency for Research on Cancer announced initiating a new research initiative financed by the European Union (EU). The project's primary objective is to enhance the region's cancer screening data collection systems.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Oncology Information System Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
  • 4.2.By Product and Service
    • 4.2.1.Patient Information Systems
    • 4.2.2.Treatment Planning Systems
    • 4.2.3.Treatment Management & Medical Image Analysis Systems
    • 4.2.4.Consulting & Optimization Services
    • 4.2.5.Implementation Services
    • 4.2.6.Post-sale & Maintenance Services
  • 4.3.By Application
    • 4.3.1.Medical Oncology
    • 4.3.2.Radiation Oncology
    • 4.3.3.Surgical Oncology
  • 4.4.By End-user
    • 4.4.1.Hospitals
    • 4.4.2.Cancer Care Centres
    • 4.4.3.Government Institutes
    • 4.4.4.Research Facilities
    • 4.4.5.Others
  • 4.5.By Region
    • 4.5.1.North America
    • 4.5.2.Europe
    • 4.5.3.Asia-Pacific
    • 4.5.4.South End-user America
    • 4.5.5.Middle East and Africa
  • 4.6.By Company Market Share (%), 2023

5.Global Oncology Information System Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
    • 5.1.2.By Product and Service
      • 5.1.2.1.Patient Information Systems
      • 5.1.2.2.Treatment Planning Systems
      • 5.1.2.3.Treatment Management & Medical Image Analysis Systems
      • 5.1.2.4.Consulting & Optimization Services
      • 5.1.2.5.Implementation Services
      • 5.1.2.6.Post-sale & Maintenance Services
    • 5.1.3.By Application
      • 5.1.3.1.Medical Oncology
      • 5.1.3.2.Radiation Oncology
      • 5.1.3.3.Surgical Oncology
    • 5.1.4.By End-user
      • 5.1.4.1.Hospitals
      • 5.1.4.2.Cancer Care Centres
      • 5.1.4.3.Government Institutes
      • 5.1.4.4.Research Facilities
      • 5.1.4.5.Others
    • 5.1.5.United States*
      • 5.1.5.1.Market Size & Forecast
      • 5.1.5.1.1.By Value
      • 5.1.5.2.By Product and Service
      • 5.1.5.2.1.Patient Information Systems
      • 5.1.5.2.2.Treatment Planning Systems
      • 5.1.5.2.3.Treatment Management & Medical Image Analysis Systems
      • 5.1.5.2.4.Consulting & Optimization Services
      • 5.1.5.2.5.Implementation Services
      • 5.1.5.2.6.Post-sale & Maintenance Services
      • 5.1.5.3.By Application
      • 5.1.5.3.1.Medical Oncology
      • 5.1.5.3.2.Radiation Oncology
      • 5.1.5.3.3.Surgical Oncology
      • 5.1.5.4.By End-user
      • 5.1.5.4.1.Hospitals
      • 5.1.5.4.2.Cancer Care Centres
      • 5.1.5.4.3.Government Institutes
      • 5.1.5.4.4.Research Facilities
      • 5.1.5.4.5.Others
    • 5.1.6.Canada
    • 5.1.7.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East & Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Product and Service
  • 6.2.By Application
  • 6.3.By End-user
  • 6.4.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat from New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Patent Landscape
  • 9.2.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)

11.Case Studies

12.Key Players Outlook

  • 12.1.Siemens Healthineers
    • 12.1.1.Company Details
    • 12.1.2.Key Management Personnel
    • 12.1.3.Products & Services
    • 12.1.4.Financials (As reported)
    • 12.1.5.Key Market Focus & Geographical Presence
    • 12.1.6.Recent Developments
  • 12.2.F. Hoffmann-La Roche AG
  • 12.3.McKesson Corporation
  • 12.4.Koninklijke Philips N.V.
  • 12.5.GE HealthCare Technologies, Inc.
  • 12.6.Elekta Medical Systems India Pvt. Ltd.
  • 12.7.IBM Watson Health
  • 12.8.Oracle Cerner
  • 12.9.Epic Systems Corporation
  • 12.10.RaySearch Laboratories AB

13.Strategic Recommendations

14.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 3.Global Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 4.Global Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 5.Global Oncology Information System Market Share (%), By Region, 2017-2031F
  • Figure 6.North America Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 7.North America Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 8.North America Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 9.North America Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 10.North America Oncology Information System Market Share (%), By Country, 2017-2031F
  • Figure 11.United States Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 12.United States Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 13.United States Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 14.United States Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 15.Canada Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 16.Canada Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 17.Canada Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 18.Canada Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 19.Mexico Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 20.Mexico Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 21.Mexico Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 22.Mexico Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 23.Europe Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 24.Europe Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 25.Europe Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 26.Europe Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 27.Europe Oncology Information System Market Share (%), By Country, 2017-2031F
  • Figure 28.Germany Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 29.Germany Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 30.Germany Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 31.Germany Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 32.France Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 33.France Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 34.France Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 35.France Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 36.Italy Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 37.Italy Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 38.Italy Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 39.Italy Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 40.United Kingdom Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 41.United Kingdom Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 42.United Kingdom Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 43.United Kingdom Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 44.Russia Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 45.Russia Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 46.Russia Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 47.Russia Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 48.Netherlands Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 49.Netherlands Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 50.Netherlands Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 51.Netherlands Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 52.Spain Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 53.Spain Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 54.Spain Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 55.Spain Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 56.Turkey Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 57.Turkey Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 58.Turkey Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 59.Turkey Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 60.Poland Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 61.Poland Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 62.Poland Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 63.Poland Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 64.South America Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.South America Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 66.South America Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 67.South America Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 68.South America Oncology Information System Market Share (%), By Country, 2017-2031F
  • Figure 69.Brazil Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 70.Brazil Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 71.Brazil Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 72.Brazil Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 73.Argentina Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 74.Argentina Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 75.Argentina Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 76.Argentina Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 77.Asia-Pacific Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 78.Asia-Pacific Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 79.Asia-Pacific Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 80.Asia-Pacific Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 81.Asia-Pacific Oncology Information System Market Share (%), By Country, 2017-2031F
  • Figure 82.India Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 83.India Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 84.India Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 85.India Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 86.China Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 87.China Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 88.China Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 89.China Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 90.Japan Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 91.Japan Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 92.Japan Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 93.Japan Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 94.Australia Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 95.Australia Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 96.Australia Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 97.Australia Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 98.Vietnam Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 99.Vietnam Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 100.Vietnam Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 101.Vietnam Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 102.South Korea Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 103.South Korea Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 104.South Korea Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 105.South Korea Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 106.Indonesia Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 107.Indonesia Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 108.Indonesia Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 109.Indonesia Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 110.Philippines Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 111.Philippines Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 112.Philippines Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 113.Philippines Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 114.Middle East & Africa Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 115.Middle East & Africa Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 116.Middle East & Africa Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 117.Middle East & Africa Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 118.Middle East & Africa Oncology Information System Market Share (%), By Country, 2017-2031F
  • Figure 119.Saudi Arabia Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 120.Saudi Arabia Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 121.Saudi Arabia Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 122.Saudi Arabia Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 123.UAE Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 124.UAE Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 125.UAE Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 126.UAE Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 127.South Africa Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 128.South Africa Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 129.South Africa Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 130.South Africa Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 131.By Product and Service Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 132.By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 133.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 134.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023